Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move: (TSX:
$APHA.TO), (CSE: $GGB.C), (TSX: $NEPT.TO), (CSE: $TGIF.C), (CSE: $CHM.C)
Delta, Kelowna, BC –April 15,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insights from thought leaders and
experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/04151APHA-GGB-NEPT-TGIF-CHM.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another Investorideas.com “potcast” looking at
cannabis news, stocks to watch as well as insights from experts and industry
leaders.
Today
we are looking at announcements from Aphria Inc. (TSX: APHA) (NYSE: APHA), Green Growth Brands
Inc. (CSE: GGB) (OTC:GGBXF), Neptune Wellness
Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), 1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF) and Chemistree
Technology Inc. (CSE: CHM) (OTCQB: CHMJF).
Aphria Inc. (TSX: APHA) (NYSE: APHA) today
announced that it
has entered into a series of transactions that will accelerate the expiry date
to April 25, 2019 for the previously announced take-over bid by Green Growth Brands Inc. (CSE: GGB) (OTC:GGBXF) and will terminate the arrangements with
GA Opportunities Corp. for consideration of $89.0 million.
Irwin
D. Simon, Aphria's Chairman and Interim Chief Executive Officer stated,
"We are very pleased to move forward with this favorable resolution as we
continue to focus on the long-term growth of our leading cannabis business. We
plan to use the $89.0 million in proceeds from the transaction to fund our
strategic global expansion initiatives. On behalf of our Board of Directors and
management team, we continue to recommend that Aphria shareholders reject the
GGB offer and do not tender their Aphria shares to the GGB offer."
Aphria
has entered into a shortened deposit period agreement with GGB to facilitate
the acceleration of the expiry of GGB's offer to purchase all of the issued and
outstanding shares of Aphria (the "GGB Offer"). In that regard,
Aphria has agreed to reduce the initial deposit period of the bid to 92 days
from January 23, 2019, the date that GGB commenced the GGB Offer. GGB will be
mailing a Notice of Variation providing that the GGB Offer will expire at 5:00
p.m. on April 25, 2019. Based on the closing price of $3.86 per GGB share on
the Canadian Securities Exchange ("CSE") on April 12, 2019, the
implied consideration under the GGB Offer would be $6.07 per Aphria share,
representing a significant 54.7% discount to Aphria's closing price on the
Toronto Stock Exchange of $13.41 per share on the same day.
In
light of the foregoing and for the reasons previously disclosed, Aphria
continues to recommend that Aphria shareholders reject the GGB Offer and do not
tender their Aphria shares to the GGB Offer.
Neptune Wellness
Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced that its Solutions Business has begun
offering turnkey product development solutions with hemp-derived ingredients to
business customers in the United States. A U.S.-based supply chain of licenced
hemp extract producers has been established, and initial purchase orders are
now being processed.
Neptune
boasts long-standing experience in the management of custom and white label
turnkey product development solutions comprising a diverse array of product
forms including softgels, liquids, topicals, emulsions, and water-dispersible
powders. Branded ingredients and products that have contributed to Neptune's
success, such as MaxSimil® and ECSentialsTM formulations, could
potentially be used in unique combinations with hemp ingredients, particularly
as the U.S. regulatory framework around hemp extracts and cannabidiol (CBD)
evolves.
"The
U.S. market for hemp is developing rapidly and represents a significant
opportunity for the consumer products industry. Neptune is now offering
products and services to American brands that want to create a unique
hemp-based portfolio, with products made exclusively in the U.S. for the
U.S." said Jim Hamilton, President and CEO of Neptune.
1933 Industries Inc., a licensed cultivator and producer of
cannabis flower and concentrates and manufacturer of hemp-derived CBD wellness
products, announced the
execution of an exclusive licensing agreement (the "Agreement")
between Gotti's Gold Ex LLC and Alternative Medicine Association LC
("AMA"), for the launch of Gotti's Gold in Nevada, a new line of branded cannabis products in partnership
with legendary hip-hop artist Kurupt. The Agreement expires on November
9, 2019, and is subject to
renewal for an additional twelve (12) month term.
Gotti's Gold is an exclusive premium
collection of fine cannabis products intended to appeal to adult-users of all
demographics. Having served as Executive Vice President of Death Row Records,
Kurupt is one of the most influential hip-hop artists in the business, playing
an instrumental role in the launch of the early careers of some of the biggest
names in hip-hop from 2Pac and Warren G to Dr. Dre and Snoop Dogg. Kurupt
entered the cannabis business as the original creator of now world-famous
Moonrocks, and has been working with AMA since 2017, when it launched "The
Real Kurupt's Moonrocks" in Nevada.
"We've teamed-up once again with the
legendary Kurupt and we are proud to continue to build on our relationship with
the launch of Gotti's Gold in the active Las Vegas market," said Mr. Joe
Bleackley, Chief Operating Officer of the Company. "AMA has delivered
consistent product quality and we are honored that Kurupt has selected AMA as a
partner for his new line of premium products."
Chemistree Technology Inc. (CSE:
CHM) (OTCQB:
CHMJF).
announced that
its wholly owned U.S. subsidiary, American CHM Investments Inc. has signed a
letter of intent to partner with Applied Cannabis Sciences of New Jersey, a New
Jersey-based medical retail dispensary applicant in the upcoming New Jersey
round of Request for Applications, which is anticipated in 2020.
Applied Cannabis Sciences has been
established by a team of seasoned professionals from the legal medicinal and
adult use marijuana industry whose collective experience exceeds 50 years and
includes over 20 cultivation, processing, and manufacturing licenses across
four states (Washington, Oregon, California, and Colorado) within the U.S. The
ACS team is predominantly made up of professionals that reside and currently
operate from New Jersey and maintain multiple strategic relationships. Recently
appointed Chemistree board member, Nico Escondido, is a founding member of the
ACS team.
The application, if successful, will
provide ACS with a fully integrated cultivation, manufacturing/processing and
retail sales license in the state of New Jersey of which there are currently
only 12 issued.
"We are excited about partnering
with ACS, a highly experienced group recognized in the medical and recreational
cannabis space that bring a track record of innovation and success. The potential to expand Chemistree's
presence outside of California and Washington state and ultimately introduce
our signature brand Sugarleaf to the large New Jersey consumer base by
partnering with ACS is consistent with our growth strategy," stated Karl
Kottmeier, President of Chemistree. "New Jersey is home to over nine
million people currently being served by only 12 cannabis operators in its
medical program. New Jersey is a logical place for Chemistree to expand into
and bring the Sugarleaf brand to the New Jersey market. I would like to
specifically thank Nico Escondido, our newest board member for the introduction
to this exciting opportunity and I am impressed with the significant impact he
is already clearly having on our Company."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher
of third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves
risk and possible loss of investment. This site is currently compensated for
news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast
and news publication services and costs https://www.investorideas.com/News-Upload/
Global investors must adhere to
regulations of each country.
Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
